A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease (NCT05733832)
A Randomized Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
🩺 Plain-English Summary (8th-Grade Level)
Patients with complications of advanced liver disease often have difficulties after hospital discharge that result in early hospital readmission. Poor outcomes for these patients during this transitional time could be improved through the use of innovative transitional care models. This proposal aims to examine the effect of a transitional care model, The Transitional Liver Clinic (TLC), in reducing hospital re-admissions, improving quality of life, and improving patient experience.
Who can join: Review the eligibility criteria below.
Location: University of Chicago — Chicago, Illinois
Age range: 18 Years
🧪 Interventions in This Study
- Transitional Liver Clinic (TLC) (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- University of Chicago — Chicago, Illinois
- Indiana University Division of Gastroenterolgy and Hepatology — Indianapolis, Indiana
- University of Michigan — Ann Arbor, Michigan
- Albert Einstein Healthcare Network — Philadelphia, Pennsylvania
📞 Contact the Study Coordinator
Phone: (317) 278-6305
Email: jacmccar@iu.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Liver Diseases
- Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use — San Francisco, California
- Liver Cancer Prevention Randomized Control Trial — Houston, Texas
- RESTORE Declined Livers Study — St Louis, Missouri
- Liver Micro Flow - MRI — Madison, Wisconsin
- The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial — Chicago, Illinois
- MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease — Chicago, Illinois
Explore by condition: All Liver Diseases clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.